Table of Contents: July 2016

Texas Medicine Logo(1)

Volume 112, Number 7 — July 2016

COVER STORY (pages 24-32)

Drug Debacle
Medicaid's Vendor Drug Program is under examination by the Texas Legislature. TMA's Physicians Medicaid Congress is seizing the opportunity to call for an administrative overhaul of a drug benefit physicians describe as unnecessarily complicated and confusing. By Amy Lynn Sorrel

PUBLIC HEALTH (pages 33-38)

One Last Shot 
Texas' right-to-try law makes experimental drugs more accessible to terminally ill patients when all other FDA-approved treatment options are unavailable or are unlikely to prolong life. By Joey Berlin

PROFILE (pages 39-46) 

Physician at the Helm
TMA Board of Trustees' Dan McCoy, MD, talks to Texas Medicine about his new role as president of Blue Cross and Blue Shield of Texas. By Amy Lynn Sorrel

QUALITY (pages 47-52)

Bracing for MACRA
TMA's Medicare and CHIP Reauthorization Act Resource Center is poised to equip physicians for the paradigm shift in Medicare payment. By Amy Lynn Sorrel

LAW  (pages 53-59)

The Future Calls
Physicians say rules the Texas Medical Board is proposing for call coverage agreements are part of an effort to bring telehealth front and center as a core service within the health care system. By Joey Berlin 

JOURNAL (page 61)

Current Concepts on Diabetic Nephropathy and 2014 Data on Diabetic Renal Failure in Texas By Patricio A. Pazmiño, PhD, MD


Inbox (page 6)
Fact (page 7)
Focus On: MACRA (page 9)
Commentary: Our Heart of the Darkness By John Pettigrove, MD (page 11)
Rounds (pages 13-22)
Deaths (page 19)
Author Guidelines (page 62)
Tip (page 64)

Texas Medicine Main Page
Texas Medicine Back Issues